Treatment effects of the combination of ceftriaxone and valproic acid on neuronal and behavioural functions in a rat model of epilepsy
- 26 June 2021
- journal article
- research article
- Published by Wiley in Experimental Physiology
- Vol. 106 (8) , 1814-1828
Abstract
New Findings: What is the central question of this study? Imbalance of activities between GABAergic and glutamatergic systems is involved in epilepsy. It is not known whether simultaneously increasing GABAergic and decreasing glutamatergic activity using valproic acid and ceftriaxone, respectively, leads to better seizure control. What is the central question of this study? Ceftriaxone suppressed seizure and cognitive deficits and restored neuronal density and the number of newborn cells in the hippocampus in a rat model of epilepsy. Combined treatment with ceftriaxone and valproic acid showed additive effects in seizure suppression. The pathophysiology of epilepsy is typically considered as an imbalance between inhibitory GABA and excitatory glutamate neurotransmission. Valproic acid (Val), a GABA agonist, is one of the first‐line antiepileptic drugs in the treatment of epilepsy, but it exhibits adverse effects. Ceftriaxone (CEF) elevates expression of glutamate transporter‐1, enhances the reuptake of synaptic glutamate, increases the number of newborn cells and exhibits neuroprotective effects in animal studies. In this study, we evaluated effects of the combination of CEF and Val on behavioural and neuronal measures in a rat epilepsy model. Male Wistar rats were injected i.p. with pentylenetetrazol (35 mg/kg, every other day for 13 days) to induce the epilepsy model. Ceftriaxone (10 or 50 mg/kg), Val (50 or 100 mg/kg) or the combination of CEF and Val were injected daily after the fourth pentylenetetrazol injection for seven consecutive days. Epileptic rats exhibited seizure and impairments in motor and cognitive functions. Treatment with CEF and Val reduced the seizure and enhanced motor and cognitive functions in a dose‐dependent manner. The combination of CEF (10 mg/kg) and Val (50 mg/kg) improved behaviours considerably. Histologically, compared with control animals, epileptic rats exhibited lower neuronal density and a reduction in hippocampal newborn cells but higher apoptosis in the basolateral amygdala, all of which were restored by the treatment with CEF, Val or the combination of CEF and Val. The study findings demonstrated that the combination of low doses of CEF and Val has beneficial effects on seizure suppression, neuroprotection and improvement in motor and cognitive functions in epilepsy.Keywords
Funding Information
- Ministry of Science and Technology (MOST 108‐2410‐H‐040‐002‐MY2, MOST 106‐2410‐H‐040‐003‐MY2, MOST 106‐2320‐B‐040‐009‐MY3, MOST 106‐2320‐B‐040‐021‐MY3, MOST‐108‐2320‐B‐040‐013)
- Taipei City Government (10701‐62‐067)
This publication has 94 references indexed in Scilit:
- Lack of effect of ceftriaxone, a GLT-1 transporter activator, on spatial memory in micePharmacology Biochemistry and Behavior, 2013
- Increased Seizure Latency and Decreased Severity of Pentylenetetrazol-Induced Seizures in Mice after Essential Oil AdministrationEpilepsy Research and Treatment, 2013
- Reduction of EEG Theta Power and Changes in Motor Activity in Rats Treated with CeftriaxonePLOS ONE, 2012
- Penetration of Drugs through the Blood-Cerebrospinal Fluid/Blood-Brain Barrier for Treatment of Central Nervous System InfectionsClinical Microbiology Reviews, 2010
- β-lactamase inhibitors display anti-seizure properties in an invertebrate assayNeuroscience, 2010
- Expression and distribution of ‘high affinity’ glutamate transporters GLT1, GLAST, EAAC1 and of GCPII in the rat peripheral nervous systemJournal of Anatomy, 2008
- Chronic epilepsy and cognition: A longitudinal study in temporal lobe epilepsyAnnals of Neurology, 2003
- Hippocampal sclerosis is a progressive disorder: A longitudinal volumetric MRI studyAnnals of Neurology, 2003
- Lamotrigine substitution study: evidence for synergism with sodium valproate?Epilepsy Research, 1997
- Increase of Human Plasma GABA by Sodium ValproateEpilepsia, 1980